journal article·2011-05

In vitro osteoblastic differentiation of human mesenchymal stem cells and human dental pulp stem cells on poly‐L‐lysine‐treated titanium‐6‐aluminium‐4‐vanadium

Daniela Galli, Laura Benedetti, Matilde Bongio, Valentina Maliardi, Giulia Silvani, Gabriele Ceccarelli, Flavio Ronzoni, Silvio Conte, Francesco Benazzo, Antonio Graziano, Gianpaolo Papaccio, Maurilio Sampaolesi, Maria Gabriella Cusella De Angelis

Publisher page

Abstract

Abstract Three‐dimensional (3D) titanium‐6‐aluminium‐4‐vanadium (Ti6Al4V) is a widely used biomaterial for orthopedic prosthesis and dental implants; thanks to its very high‐mechanical strength and resistance to corrosion. Human mesenchymal stem cells (hMSCs) and dental pulp stem cells (hDPSCs) are responsible for bone regeneration following colonization of prosthesis or dental implants. Both hMSCs and hDPSCs have lower ability to colonize this biomaterial in comparison with tissue culture‐treated plastic. Both hMSCs and hDPSCs show lack of focal adhesion kinase (FAK) activation when grown on Ti6Al4V. This signal is restored in the presence of poly‐L‐lysine (poly‐L‐lys). Poly‐L‐lys has been used as part of organoapatite or together with zinc and calcium ions. Our results suggest that poly‐L‐lys alone induces FAK activation through β1‐INTEGRIN, because the presence of β1‐INTEGRIN blocking antibody avoided FAK autophosphorylation. Presence of poly‐L‐lys also increases expression of osteoblastic differentiation marker genes in hMSCs and hDPSCs grown on Ti6Al4V. © 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2011.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Electrospun Nanofibers in Biomedical Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (33)

Show source-provided references
1. 10.1126/science.849352910.1126/science.8493529 ↗
2. 10.3109/1745367990899782610.3109/17453679908997826 ↗
3. 10.4103/0022-3859.3221510.4103/0022-3859.32215 ↗
4. 10.1177/002203450934086710.1177/0022034509340867 ↗
5. 10.1016/j.biomaterials.2007.10.04310.1016/j.biomaterials.2007.10.043 ↗
6. 10.1002/jcp.2117510.1002/jcp.21175 ↗
7. 10.1016/j.biomaterials.2005.01.06010.1016/j.biomaterials.2005.01.060 ↗
8. 10.1016/j.biomaterials.2007.04.00310.1016/j.biomaterials.2007.04.003 ↗
9. 10.1016/S0006-3495(02)75535-510.1016/S0006-3495(02)75535-5 ↗
10. 10.1038/sj.emboj.760096010.1038/sj.emboj.7600960 ↗
11. 10.1016/j.bioeng.2007.07.00410.1016/j.bioeng.2007.07.004 ↗
12. 10.1002/jbm.a.3183410.1002/jbm.a.31834 ↗
13. 10.1002/(SICI)1097-4636(19991215)47:4<504::AID-JBM6>3.0.CO;2-O10.1002/(SICI)1097-4636(19991215)47:4<504::AID-JBM6>3.0.CO;2-O ↗
14. 10.1016/j.biomaterials.2005.01.03910.1016/j.biomaterials.2005.01.039 ↗
15. 10.1016/j.biomaterials.2005.01.04310.1016/j.biomaterials.2005.01.043 ↗
16. 10.1016/j.bbrc.2006.06.11010.1016/j.bbrc.2006.06.110 ↗
17. 10.1016/j.matbio.2006.10.00110.1016/j.matbio.2006.10.001 ↗
18. 10.1002/jcb.2107410.1002/jcb.21074 ↗
19. 10.3324/haematol.2009.00617110.3324/haematol.2009.006171 ↗
20. 10.1097/SCS.0b013e31816aabc810.1097/SCS.0b013e31816aabc8 ↗
21. 10.1002/jor.110014060610.1002/jor.1100140606 ↗
22. 10.1097/01.pas.0000202048.28203.2510.1097/01.pas.0000202048.28203.25 ↗
23. 10.1186/1471-2164-8-7010.1186/1471-2164-8-70 ↗
24. 10.1002/jbm.a.3202110.1002/jbm.a.32021 ↗
25. 10.1177/002203450934086710.1177/0022034509340867 ↗
26. 10.1091/mbc.E08-01-007610.1091/mbc.E08-01-0076 ↗
27. 10.1016/j.yexcr.2006.09.01310.1016/j.yexcr.2006.09.013 ↗
28. 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F ↗
29. 10.1002/jbm.a.3026410.1002/jbm.a.30264 ↗
30. 10.1007/s10856-009-3976-x10.1007/s10856-009-3976-x ↗
31. 10.1016/j.bbrc.2006.07.21410.1016/j.bbrc.2006.07.214 ↗
32. 10.1002/jcb.2235610.1002/jcb.22356 ↗
33. 10.1016/j.exphem.2009.04.00410.1016/j.exphem.2009.04.004 ↗